Azzad Asset Management Inc. ADV Has $2.77 Million Holdings in Corteva, Inc. (NYSE:CTVA)

Azzad Asset Management Inc. ADV increased its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 11.6% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 47,997 shares of the company’s stock after acquiring an additional 4,986 shares during the quarter. Azzad Asset Management Inc. ADV’s holdings in Corteva were worth $2,768,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. &PARTNERS raised its stake in Corteva by 4.3% during the 1st quarter. &PARTNERS now owns 4,829 shares of the company’s stock worth $278,000 after buying an additional 200 shares during the period. Essex Financial Services Inc. raised its stake in shares of Corteva by 3.2% in the 3rd quarter. Essex Financial Services Inc. now owns 6,883 shares of the company’s stock valued at $352,000 after purchasing an additional 215 shares during the period. Baxter Bros Inc. raised its stake in shares of Corteva by 1.2% in the 4th quarter. Baxter Bros Inc. now owns 17,576 shares of the company’s stock valued at $842,000 after purchasing an additional 215 shares during the period. Moody National Bank Trust Division raised its stake in shares of Corteva by 1.2% in the 1st quarter. Moody National Bank Trust Division now owns 19,660 shares of the company’s stock valued at $1,134,000 after purchasing an additional 235 shares during the period. Finally, Wealthcare Advisory Partners LLC raised its stake in shares of Corteva by 4.7% in the 4th quarter. Wealthcare Advisory Partners LLC now owns 5,361 shares of the company’s stock valued at $257,000 after purchasing an additional 242 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.

Insider Activity

In other news, insider Samuel R. Eathington sold 31,686 shares of Corteva stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $57.64, for a total value of $1,826,381.04. Following the completion of the sale, the insider now directly owns 53,854 shares in the company, valued at $3,104,144.56. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other Corteva news, SVP Cornel B. Fuerer sold 39,736 shares of the business’s stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $57.41, for a total transaction of $2,281,243.76. Following the completion of the transaction, the senior vice president now directly owns 126,628 shares in the company, valued at $7,269,713.48. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Samuel R. Eathington sold 31,686 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $57.64, for a total transaction of $1,826,381.04. Following the transaction, the insider now owns 53,854 shares of the company’s stock, valued at $3,104,144.56. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 83,556 shares of company stock worth $4,795,016. Corporate insiders own 0.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CTVA. OTR Global reissued a “negative” rating on shares of Corteva in a research note on Friday, June 7th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $65.00 price target on shares of Corteva in a research note on Wednesday, June 12th. Royal Bank of Canada raised their price objective on Corteva from $62.00 to $64.00 and gave the company an “outperform” rating in a report on Monday, May 6th. Canaccord Genuity Group raised their price objective on Corteva from $60.00 to $65.00 and gave the company a “buy” rating in a report on Friday, May 3rd. Finally, BMO Capital Markets raised their price objective on Corteva from $64.00 to $67.00 and gave the company an “outperform” rating in a report on Friday, May 3rd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $63.00.

Corteva Trading Down 0.5 %

Shares of NYSE:CTVA opened at $52.48 on Thursday. Corteva, Inc. has a 12-month low of $43.22 and a 12-month high of $58.76. The stock has a market cap of $36.58 billion, a PE ratio of 66.43, a P/E/G ratio of 1.44 and a beta of 0.77. The business has a 50 day moving average of $54.68 and a 200-day moving average of $52.92. The company has a quick ratio of 0.97, a current ratio of 1.51 and a debt-to-equity ratio of 0.10.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Wednesday, May 1st. The company reported $0.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.79 by $0.10. Corteva had a return on equity of 6.68% and a net margin of 3.32%. The company had revenue of $4.49 billion during the quarter, compared to analysts’ expectations of $4.65 billion. During the same quarter in the previous year, the company posted $1.16 earnings per share. The business’s revenue was down 8.0% on a year-over-year basis. As a group, equities research analysts forecast that Corteva, Inc. will post 2.8 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 18th. Stockholders of record on Tuesday, June 4th were given a $0.16 dividend. The ex-dividend date was Tuesday, June 4th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.22%. Corteva’s payout ratio is 81.01%.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.